Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry.

Karadag O., Farisogullari B., Yagiz B., Erden A., Ademoglu Z., Kimyon G., ...More

Clinical and experimental rheumatology, vol.42, pp.130-137, 2024 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 42
• Publication Date: 2024
• Doi Number: 10.55563/clinexprheumatol/2h6ma1
• Journal Name: Clinical and experimental rheumatology
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, Veterinary Science Database
• Page Numbers: pp.130-137
• Open Archive Collection: AVESIS Open Access Collection
• Eskisehir Osmangazi University Affiliated: Yes